- Home
- ONEG vs NTRB Comparison
ONEG vs NTRB Comparison
Compare ONEG & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONEG | NTRB |
|---|---|---|
| Founded | 2021 | 2016 |
| Country | Hong Kong | United States |
| Employees | 26 | 3 |
| Industry | Homebuilding | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.3M | 36.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ONEG | NTRB |
|---|---|---|
| Price | $1.16 | $2.96 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 253.2K | 9.7K |
| Earning Date | 01-14-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $30.17 |
| Revenue Next Year | N/A | $3,394.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.72 | $2.90 |
| 52 Week High | $14.95 | $9.21 |
Technical Indicators
Market Signals| Indicator | ONEG | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 42.44 | 37.76 |
| Support Level | $1.13 | $2.90 |
| Resistance Level | $1.98 | $3.67 |
| Average True Range (ATR) | 0.19 | 0.20 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 7.69 | 5.66 |
Price Performance
Historical ComparisonAbout ONEG OneConstruction Group Limited Ordinary Shares
OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. The company is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction project includes performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.